Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study
- Resource Type
- Article
- Authors
- Trněný, Marek; Avigdor, Abraham; McKinney, Matthew S.; Paneesha, Shankara; Wahlin, Björn E.; Hrom, John S.; Cunningham, David; Morley, Nicholas; Canales, Miguel; Bastos-Oreiro, Mariana; Belada, David; Devizzi, Liliana; Zheng, Fred; DeMarini, Douglas J.; Jiang, Wei; Jiang, Ping; Lynch, Ryan C.
- Source
- In eClinicalMedicine September 2023 63
- Subject
- Language
- ISSN
- 2589-5370